Top compounds associated with response to RP13-210D15.9


Feature Type Standardized
Nominal ANOVA
mRNA sitagliptin CTRPv2 pan-cancer AAC 0.0049 0.9
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.0025 0.9
mRNA SR1001 CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 0.0044 0.9
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.0023 0.9
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.002 0.9
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC -0.0045 0.9
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.0022 0.9
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0022 1
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.003 1
Download CSV